The Medicines Company (NASDAQ:MDCO): Stochastic Analysis


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of The Medicines Company (NASDAQ:MDCO) for the period of 9-Day stands at 95.73% while the stochastic %D for the same period stands at 79.23%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of The Medicines Company (NASDAQ:MDCO) signals “Buy” while other important signals like the 20-Day Moving Average Vs. Price signals “Buy”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for The Medicines Company (NASDAQ:MDCO) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently The Medicines Company (NASDAQ:MDCO)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Medicines Company acquires, develops and commercializes biopharmaceutical products in late stages of development. U.S. Food and Drug Administration intends to approve its first product, Angiomax, for use in the treatment of patients with unstable angina undergoing coronary balloon angioplasty.  The company is also developing Angiomax for additional potential applications for use in the treatment of ischemic heart disease, a condition which occurs when organs receive an inadequate supply of oxygen as a result of decreased blood flow.

Previous Day Activity Analysis

On the last trading day, The Medicines Company (NASDAQ:MDCO) opened the session at $31.01 and after going up 2.69% closed at $31.73. The stock gained 0.72 points in the last trade.

The Medicines Company (NASDAQ:MDCO)’s stock fluctuated in the range of $31.01 and $31.86 during the previous active session. The Medicines Company (NASDAQ:MDCO) traded with the volume of 1.5 Million with average volume of 1.29 Million. The stock has MEDIUM volatility on the last trading session.

Currently the Beta for the company remains at 0.67 while ATR (Average True Range) and RSI (Relative Strength Index) are at 1.23 and 50.49 respectively.

Currently the Insider Ownership of the shares of The Medicines Company (NASDAQ:MDCO) is at 2.7% and the shares outstanding are 70.74 Million.

Important Ratio Analysis

Some important ratios to consider here for The Medicines Company (NASDAQ:MDCO) are discussed below:

Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 26.41 and 12.2 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 10.74 and 0 correspondingly.

The Quick Ratio of The Medicines Company (NASDAQ:MDCO) stands at 1.8 while the Current Ratio depicts the value of 2.3.

Return on Assets ROA of The Medicines Company (NASDAQ:MDCO) is at -47.9% whereas, Return on Equity ROE and Return of Investment ROI of The Medicines Company (NASDAQ:MDCO) stand at -160.5% and -27.6% respectively.

Stock Performance Analysis

The stock performance of The Medicines Company (NASDAQ:MDCO) on the basis of 5 day trade show the jump of 6.73% whereas, the monthly performance of the stock shows decrease of -9.88%.

The quarterly performance of the stock remained in red zone with the value of -16.28% while six month performance of the shares of The Medicines Company (NASDAQ:MDCO) remained bearish with the count of -33.1%.

The yearly and YTD performance of The Medicines Company (NASDAQ:MDCO) remained down at -9.34% and -6.51% respectively.